Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The Group has obtained approval from the China National Drug Administration for the production of phenobibrate choline sustained-release capsules (135mg), which is a Class 4 chemical drug, which is deemed to have passed the consistency evaluation.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The Group has obtained approval from the China National Drug Administration for the production of phenobibrate choline sustained-release capsules (135mg), which is a Class 4 chemical drug, which is deemed to have passed the consistency evaluation.